Emerging influenza viruses and the prospect of a universal influenza virus vaccine

Biotechnology Journal
Florian Krammer

Abstract

Influenza viruses cause annual seasonal epidemics and pandemics at irregular intervals. Several cases of human infections with avian and swine influenza viruses have been detected recently, warranting enhanced surveillance and the development of more effective countermeasures to address the pandemic potential of these viruses. The most effective countermeasure against influenza virus infection is the use of prophylactic vaccines. However, vaccines that are currently in use for seasonal influenza viruses have to be re-formulated and re-administered in a cumbersome process every year due to the antigenic drift of the virus. Furthermore, current seasonal vaccines are ineffective against novel pandemic strains. This paper reviews zoonotic influenza viruses with pandemic potential and technological advances towards better vaccines that induce broad and long lasting protection from influenza virus infection. Recent efforts have focused on the development of broadly protective/universal influenza virus vaccines that can provide immunity against drifted seasonal influenza virus strains but also against potential pandemic viruses.

References

Jan 1, 1991·Archives of Virology·A S Beare, R G Webster
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B E JohanssonE D Kilbourne
Apr 1, 1974·The Journal of Infectious Diseases·R B CouchE D Kilbourne
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·B E Johansson, E D Kilbourne
Apr 11, 2003·Vaccine·Catherine Gerdil
Dec 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Wenjun MaJürgen A Richt
Feb 24, 2009·Nature Structural & Molecular Biology·Jianhua SuiWayne A Marasco
Mar 3, 2009·Science·Damian C EkiertIan A Wilson
Apr 8, 2009·Expert Review of Vaccines·Michael SchotsaertXavier Saelens
Apr 17, 2009·Vaccine·Rebecca J CoxLars R Haaheim
Apr 29, 2009·Expert Review of Vaccines·P Noel BarrettM Keith Howard
Jun 24, 2010·Trends in Molecular Medicine·Florian Krammer, Reingard Grabherr
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Gayathri BommakantiRaghavan Varadarajan
Jul 28, 2010·PloS One·José M Aguilar-YáñezMario M Alvarez
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Taia T WangPeter Palese
Dec 15, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tamara K BerthoudSarah C Gilbert
Dec 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karim El BakkouriXavier Saelens
Jan 12, 2011·The Journal of Experimental Medicine·Jens WrammertPatrick C Wilson
Mar 9, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Guihong ZhangXiu-Feng Wan
Mar 11, 2011·Nature·Gary J NabelJulie E Ledgerwood
Jul 9, 2011·Science·Damian C EkiertJaap Goudsmit
Aug 23, 2011·Expert Review of Vaccines·Michael L PerdueRobert Huebner
Sep 1, 2011·MBio·Peter Palese, Taia T Wang
Oct 19, 2011·Journal of Biomedicine & Biotechnology·Marine L B HillaireGuus F Rimmelzwaan
Dec 17, 2011·Vaccine·Hartmut J EhrlichP Noel Barrett
Jan 24, 2012·Vaccine·Manon M J Cox
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Natalie PicaPeter Palese
Feb 10, 2012·Journal of Clinical Immunology·Jacob AtsmonTamar Ben-Yedidia

❮ Previous
Next ❯

Citations

Jan 20, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Karin L LeeNicole F Steinmetz
Dec 20, 2015·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Ankita MalikSatish Kumar Gupta
Mar 15, 2016·Current Opinion in Virology·Emma J GrantKatherine Kedzierska
May 7, 2015·Biotechnology Journal·Reingard Grabherr, Udo Reichl
Apr 9, 2016·Expert Review of Vaccines·Fu-Shi QuanSang-Moo Kang
Jun 12, 2016·Journal of Chromatography. a·Petra SteppertAlois Jungbauer
May 18, 2017·Biotechnology Journal·Sofia B CarvalhoManuel J T Carrondo
Sep 22, 2017·Human Vaccines & Immunotherapeutics·Kristin G-I MohnRebecca Jane Cox
Jan 1, 2019·Biotechnology and Bioengineering·Hayley K Charlton HumeLinda H L Lua
Oct 21, 2019·Journal of Biomedical Science·Daria MezhenskayaLarisa Rudenko
Jul 19, 2017·Vaccines·Ilaria ManiniEmanuele Montomoli
Jan 9, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leonardo D Estrada, Stacey Schultz-Cherry
Dec 21, 2019·Phytotherapy Research : PTR·Marcella DenaroDomenico Trombetta
Mar 7, 2019·Nature Reviews. Immunology·Florian Krammer
Nov 2, 2019·Immunology Letters·Miao LiHua-Ji Qiu
Jul 23, 2020·International Journal of Biological Macromolecules·S C TeixeiraD S Lopes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Drug Discovery
Florian Krammer, Peter Palese
Expert Opinion on Emerging Drugs
Pritish K Tosh, Gregory A Poland
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Tamara K BerthoudSarah C Gilbert
Acta biochimica Polonica
Malgorzata Kesik-Brodacka, Grazyna Plucienniczak
© 2022 Meta ULC. All rights reserved